Monitoring clinical trials with a conditional probability stopping rule.
Conditional probability procedures offer a flexible means of performing sequential analysis of clinical trials. Since these procedures are not based on repeated significance test, the number and schedule of the interim analyses is less important than with group sequential procedures. Their main disadvantage is that the magnitude of their effect on the significance level is difficult to assess. This paper describes a conditional probability procedure which attempts to maintain the overall significance level by balancing the probabilities of false early rejection and false early acceptance. Monte Carlo sampling results suggest that this procedure can achieve a large reduction in expected sample size without greatly affecting either the significance level or power of the trial.
Snapinn
S M
SM
Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
D016010:Binomial Distribution; D002986:Clinical Trials as Topic / Q000592:standards*; D004656:Enalapril / Q000627:therapeutic use; D006801:Humans; D009010:Monte Carlo Method; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D011336:Probability; D012494:Sampling Studies
D004656:Enalapril